hidden pixel

Abbott Laboratories Information

Abbott Laboratories (NYSE: ABT) is an American-based global, diversified (multi-division) pharmaceuticals and health care products company. It has 90,000 employees and operates in over 130 countries.[3] The company headquarters are in Abbott Park, North Chicago, Illinois. The company was founded by Chicago physician, Dr. Wallace Calvin Abbott in 1888. In 2010, Abbott had over $35 billion in revenue.

In 1985, the company developed the first HIV blood screening test. The company's drug portfolio includes HUMIRA, a drug for rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, moderate to severe chronic psoriasis and juvenile idiopathic arthritis; Norvir, a treatment for HIV; Depakote, an anticonvulsant drug; and Synthroid, a synthetic thyroid hormone. Abbott also has a broad range of medical devices, diagnostics and immunoassay products as well as nutritional products, including Ensure, a line of well known meal replacement shakes, and EAS, the largest producer of performance based nutritional supplements.

Abbott's in vitro diagnostics business is a world leader in immunoassays and blood screening. Abbott's broad range of medical tests and diagnostic instrument systems are used worldwide by hospitals, laboratories, blood banks, and physician offices to diagnose and monitor diseases such as HIV, hepatitis, cancer, heart failure and metabolic disorders, as well as assess other important indicators of general health. Abbott Point-of-Care manufactures diagnostic products for blood analysis to provide health care professionals critical diagnostics information accurately and immediately at the point of patient care. Abbott also provides point-of-care cardiac assays to the emergency room.

In 2011, the company was ranked as Top 20 BioPharma employers by the Science Magazine. The company has been on the list for 8 times

Contents

Organization

Abbott's core businesses focus on pharmaceuticals, medical devices and nutritional products, which have been supplemented through several notable acquisitions. The firm currently divides itself into several divisions:

It has also divested itself of less profitable businesses through sales and spinoffs. In 1964, it acquired Ross Laboratories, making Ross a wholly owned subsidiary of Abbott. In 2001, Abbott acquired Knoll, the pharmaceutical division of BASF. In 2002, Abbott divested the Selsun Blue brand to Chattem. Later in 2002, Abbott sold Clear Eyes and Murine to Prestige Brands. In 2004, Abbott spun off its hospital products division into a new 14,000 employee company named Hospira, and acquired TheraSense, a diabetes care company, which it merged with its MediSense division to become Abbott Diabetes Care. In 2006, Abbott assisted Boston Scientific in its purchase of Guidant Corporation. As part of the agreement, Abbott purchased the vascular device division of Guidant. In 2007, Ross was renamed Abbott Nutrition.

In January 2007, Abbott Laboratories agreed to sell its in vitro diagnostics and Point-of-Care diagnostics divisions to General Electric for more than $8 billion. These units were slated to be integrated into the GE Healthcare business unit. The transaction was approved by the Boards of Directors of Abbott and GE and was targeted to close in the first half of 2007. However, on July 11, 2007, Abbott announced that it had terminated its agreement with GE because both parties could not agree on terms of the deal.[4]

On September 8, 2007, Abbott completed the sale of the UK manufacturing plant at Queenborough to Aesica Pharmaceuticals, a Private equity-owned UK manufacturer. No announcements have been made restricting the movement of staff to Abbott unlike other sell outs. On February 26, 2009, Abbott completed its acquisition of Advanced Medical Optics based in Santa Ana, California. The acquisition gives Abbott a Vision Eye Care division. In February 2010 Abbott completed its $6.2 billion (EUR 4.5 billion) acquisition of Solvay Pharmaceuticals.[5] This provided Abbott with a large and complementary portfolio of pharmaceutical products and also expanding its presence in key emerging markets.[6]

On March 22, 2010, Abbott completed its acquisition of a Hollywood, Florida-based LIMS company STARLIMS. Under the terms of the deal, Abbott Laboratories acquired the company for $14 per share in an all-cash transaction valued at $123 million.[7] On April 21, 2010, Abbott has completed its acquisition of Facet Biotech Corporation, strengthening its pharmaceutical pipeline in immunology and oncology.[8] On May 21, 2010, Abbott Laboratories said it will buy Piramal Healthcare Ltd.'s Healthcare Solutions unit for $3.72 billion to become the biggest drug company in India.[9]

In October 2011, the company agreed to pay at least $1.3 billion for illegally marketing its Depakote epilepsy drug to the U.S. government and 24 states.[10]

On October 19, 2011, Abbott announced that it planned to separate into two companies, one in medical products and the other in research-based pharmaceuticals. Both will be publicly traded. The medical products company will retain the Abbott name. The research- based pharmaceuticals company will be named AbbVie. The separation is expected to complete by the end of 2012.[11][12]

Products

Some of the products produced by Abbott Laboratories, as of 2006, include:

Pharmaceuticals

Diabetes Care

Abbott CELL-DYN 1700

Diagnostics

Nutritional

Vascular

History

In 1888 at the age of 30, Dr. Wallace C. Abbott, an 1885 graduate of the University of Michigan, founded the Abbott Alkaloidal Company. At the time he was a practicing physician and owned a drug store. His innovation was the use of the active part of a medicinal plant, generally an alkaloid (morphine, quinine, strychnine, and codeine), which he formed into tiny pills which he called “dosimetric granules.” This was successful since it allowed more consistent and effective dosages for patients.[13]

In 1967, Abbott Laboratories successfully challenged the FDA on labeling regulations before the Supreme Court in Abbott Laboratories v. Gardner.

References

  1. ^ a b c Abbott Laboratories (ABT) annual SEC income statement filing via Wikinvest
  2. ^ a b Abbott Laboratories (ABT) annual SEC balance sheet filing via Wikinvest
  3. ^ a b "Abbot Laboratories Worldwide Fast Facts and Statistics", Abbott Laboratories. Retrieved March 13, 2009.
  4. ^ Bloomberg.com: Worldwide
  5. ^ Abbott Press Release (February 16, 2010). "Abbott Completes Acquisition of Solvay Pharmaceuticals". http://www.abbott.com/news-media/press-releases/Press_Release_0819.htm. Retrieved March 22, 2012.
  6. ^ "Abbott Completes Acquisition of Solvay",InfoGrok, February 16, 2010, Retrieved March 22, 2012
  7. ^ Abbott Press Release (March 22, 2010). "Abbott Completes Acquisition of STARLIMS Technologies". http://www.abbott.com/news-media/press-releases/Press_Release_0834.htm. Retrieved March 22, 2012.
  8. ^ Abbott Press Release (April 21, 2010). "Abbott Completes Acquisition of Facet Biotech". http://www.abbott.com/news-media/press-releases/Press_Release_0845.htm. Retrieved March 22, 2012.
  9. ^ Abbott Press Release (May 21, 2010). "Abbott to Become No. 1 Pharmaceutical Company in India with Acquisition of Piramal’s Healthcare Solutions Business". http://www.abbott.com/news-media/press-releases/Press_Release_0861.htm. Retrieved March 22, 2012.
  10. ^ "Abbott Said to Agree to Pay $1.3 Billion for Depakote Suits". October 22, 2011. http://www.bloomberg.com/news/2011-10-21/abbott-said-to-agree-to-pay-1-3-billion-to-end-depakote-suits.html.
  11. ^ Abbott Press Release (October 19, 2011). "Abbott to Separate into Two Leading Companies in Diversified Medical Products and Research-Based Pharmaceuticals". http://abbott.com/news-media/press-releases/2011-oct19-2.htm. Retrieved March 22, 2012.
  12. ^ Abbott Press Release (March 21, 2012). "Abbot Selects AbbVie as New Name for Future Research-Based Pharmaceutical Company". http://abbott.com/news-media/press-releases/abbott-selects-abbvie-as-new-name-for-future-researchbased-pharmaceutical-company.htm. Retrieved March 22, 2012.
  13. ^ Funding Universe: Abbott Laboratories Company History

External links

Illinois-based corporations
Fortune 500 corporations (by size–2010)
Fortune 1000 corporations (by size–2010)

Companies listed above, plus:
Other major private and public companies (alphabetically)
Pharmaceutical companies of the United States
List of pharmaceutical companies

Categories:

 

The above information uses material from Wikipedia and is licensed under the GNU Free Documentation License.
Some facts may not have been fully verified for accuracy. [Disclaimers]
This page was last archived by our server on Fri May 25 17:25:25 2012.
Displaying this page or its contents does not use any Wikimedia Foundation's resources.
The owners of this site proudly support the Wikimedia Foundation.

More Information Results for "Abbott Laboratories"
[Hide]▼
'Abbott Laboratories' Images
[Hide]▲